The 10,000 subject CANTOS trial validates inhibition of the IL-1beta inflammasome to treat inflammation and cancer

Charles Dinarello
University of Colorado, USA

15th March 2018
04:15 pm

Host: Max Löhning, DRFZ, Berlin 
Location: Max-Planck Institute for Infection Biology,
Seminar room 1+2 - Campus Charité Mitte

  imprs idi   grk2046 logo jpeg   zibi logo   mpii